Chitosan pads vs. manual compression to control bleeding sites after transbrachial arterial catheterization in a randomized trial;Randomisierte untersuchung zur anwendung eines chitosan-gerinnungspads zur blutstillung bei transbrachialen angiographien

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 177, Issue 9, 2005, Pages 1260-1266

  Poretti, Frank ^a   Rosen, T ^a   Korner B ^a   Vorwerk, D ^a  

^a KLINIKUM INGOLSTADT   (Germany)

Author keywords

Angiography; Arteries; Catheters and catheterization; Hematoma

Indexed keywords

CHITOSAN;

ADULT; ANGIOGRAPHY; ANTICOAGULANT THERAPY; ARTERY CATHETERIZATION; ARTERY DIAMETER; ARTICLE; BLEEDING; BLEEDING TIME; BRACHIAL ARTERY; CLINICAL TRIAL; COMPRESSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEMATOMA; HEMOSTASIS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUTURING METHOD;

ANGIOGRAPHY; ANTICOAGULANTS; BRACHIAL ARTERY; CATHETERIZATION, PERIPHERAL; CHITOSAN; DIABETES COMPLICATIONS; FEMALE; HEMATOMA; HEMOSTATIC TECHNIQUES; HEMOSTATICS; HUMANS; HYPERTENSION; MALE; RISK FACTORS; TIME FACTORS;

EID: 24744435386     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-858328     Document Type: Article

References (14)

1. Hamid M, Nakisa Y, Saeed A et al. Preparation of chitosan derived from shrimp's shell of Persian gulf as a blood hemostasis agent. Iranian Polymer Journal 2002; 11: 63-68
2. Rao SB, Sharma CP. Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. Jour Biomed. Mater Res 1997; 34: 21-28
3. Sanchez-Torrez G, Infante-Vazquez O, Sanchez-Miranda G et al. Mechanical factors of cardiovascular risk in systemic arterial hypertension. A new sign of arterial rigidity. Arch Cardiol Mex 2003; 73: 261-70
4. Huang R, Du J, Yang J et al. Influence of functional groups on the in vitro anticoagulant activity of chitosan sulphate. Carbohydr Res 2003; 338: 483-489
5. Hirschl M, Francesconi M, Hirschl MM. Moenkeberg media sclerosis: clinical aspects in diabetic patients. Vasa 1991; 20: 216-221
6. De a Cruz JP, Arrebola MM, Villalobos MA et al. Eur J Pharmacol 2004; 484: 19-27
7. Fattah MA, Shahee MH, Mahfouz MH. Disturbances of haemostasis in diabetes mellitus. Dis Markers 2003-2004
8. Ganotakis ES, Papadakis JA, Vrentzos GE et al. The effects of antihypertensive therapy on haemostatic parameters. Curr Pharm Des 2003; 9: 2445-2464
9. Megnien JL, Simon A, Valensi P et al. Comparative effects of diabetes mellitus and hypertension on physical properties of human large arteries. Am Coll Cardiol 1992; 20: 1562-1568
10. Chou TC, Fu E, Wu CJ et al. Chitosan enhances platelet adhesion and aggregation. Biocham Biophys Commun 2003; 302: 480-483
11. Ishihara M, Nakanishi K, Ono K et al. Photocrosslinkable chitosan as a dressing for wound occlusions and accelerator in healing process. Biomaterials 2002; 23: 833-840
12. Hoekstra A, Struszczyk H, Kivekas O. Percutaneus microcrystallin chitosan application for sealing arterial puncture sites. Biomaterials 1998; 19: 1467-1471
13. Klokkevold PR, Lew DS, Ellis DG et al. Effect of chitosan on lingual hemostasis in rabitts. J Oral Maxillofac Surg 1991; 49: 858-863
14. Fischer TH, Connolly R, Thatte HS et al. Comparison of structural and hemostatic properties of the poly-N-acety glucosamin Syvek Patch with products containing chitosan. Microsc Res Tech 2004; 63: 168-174